Axsome Therapeutics, Inc. ( AXSM) - Key Metrics
AXSM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $3.87 | -$0.56 | -$0.37 | -$0.38 |
| 2025Q3 | $3.42 | -$0.94 | $0.02 | $0.02 |
| 2025Q2 | $3.03 | -$0.97 | -$0.66 | -$0.66 |
| 2025Q1 | $2.49 | -$1.22 | -$0.89 | -$0.89 |
AXSM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -80.95 |
| 2025Q3 | ? | -32.16 |
| 2025Q2 | ? | -26.90 |
| 2025Q1 | ? | -23.98 |
AXSM
Price: $233.49
52 week price:
Earnings Per Share: -3.72 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.9 million
Ebitda: -6.3 millionMarket Capitalization: 11.2 billion